INNOVATIVE NANOPORE SEQUENCING TECHNOLOGY
    231.
    发明公开
    INNOVATIVE NANOPORE SEQUENCING TECHNOLOGY 审中-公开
    创新型纳米级定量测定仪

    公开(公告)号:EP3074134A2

    公开(公告)日:2016-10-05

    申请号:EP14865949.3

    申请日:2014-11-26

    Applicant: STC.UNM

    Abstract: Methods and apparatus for long read, label-free, optical nanopore long chain molecule sequencing. In general, the present disclosure describes a novel sequencing technology based on the integration of nanochannels to deliver single long-chain molecules with widely spaced (>wavelength), ˜1-nm aperture “tortuous” nanopores that slow translocation sufficiently to provide massively parallel, single base resolution using optical techniques. A novel, directed self-assembly nanofabrication scheme using simple colloidal nanoparticles is used to form the nanopore arrays atop nanochannels that unfold the long chain molecules. At the surface of the nanoparticle array, strongly localized electromagnetic fields in engineered plasmonic/polaritonic structures allow for single base resolution using optical techniques.

    Abstract translation: 用于长读取,无标记的光学纳米孔长链分子测序的方法和设备。 通常,本公开描述了一种新颖的测序技术,其基于纳米通道的整合以递送具有广泛间隔(>波长),〜1nm孔径“曲折”纳米孔的单个长链分子,其缓慢移位足以提供大量平行的, 使用光学技术的单基准分辨率。 使用简单的胶体纳米颗粒的新型定向自组装纳米加工方案用于在展开长链分子的纳米通道上形成纳米孔阵列。 在纳米颗粒阵列的表面,工程化等离子体/极化结构中的强定位电磁场允许使用光学技术的单碱基分辨率。

    SYSTEMS AND METHODS FOR LEVERAGING PATH DELAY VARIATIONS IN A CIRCUIT AND GENERATING ERROR-TOLERANT BITSTRINGS
    232.
    发明公开
    SYSTEMS AND METHODS FOR LEVERAGING PATH DELAY VARIATIONS IN A CIRCUIT AND GENERATING ERROR-TOLERANT BITSTRINGS 审中-公开
    系统和方法WEGVERZÖGERUNGSVARIATIONEN的电路中的开发与容错位串生产

    公开(公告)号:EP3039550A1

    公开(公告)日:2016-07-06

    申请号:EP14839346.5

    申请日:2014-08-28

    Applicant: STC.UNM

    Abstract: A Hardware-Embedded Delay PUF (HELP) leverages entropy by monitoring path stability and measuring path delays from core logic macros. HELP incorporates techniques to deal with bias. A unique feature of HELP is that it may compare data measured from different test structures. HELP may be implemented in existing FPGA platforms. HELP may leverage both path stability and within-die variations as sources of entropy.

    Abstract translation: 硬件嵌入延迟PUF(HELP)通过监视路径的稳定性和测量从核心逻辑宏路径延迟利用熵。 HELP集成了技术处理偏差。 HELP的一个独特功能是没有可能从不同的测量测试结构的数据进行比较。 HELP可以在现有FPGA平台上实现。 HELP可以利用内-变化作为熵源两个路径和稳定性。

    DNA SEQUENCING AND EPIGENOME ANALYSIS
    233.
    发明公开
    DNA SEQUENCING AND EPIGENOME ANALYSIS 有权
    DNA测序和核酸分析

    公开(公告)号:EP3027775A1

    公开(公告)日:2016-06-08

    申请号:EP14832389.2

    申请日:2014-08-01

    Abstract: This disclosure describes, in one aspect, methods for DNA sequencing and performing epigenomic analyses. Generally, the methods include immobilizing a plurality of copies of a DNA molecule on a surface, stretching at least a portion of the immobilized DNA molecules, and sequencing at least a portion of the immobilized, stretched DNA molecules.

    Abstract translation: 在一个方面,本公开描述了用于DNA测序和进行表观基因组分析的方法。 通常,这些方法包括将多个DNA分子拷贝固定在表面上,拉伸至少一部分固定的DNA分子,并对至少一部分固定的,拉伸的DNA分子进行测序。

    IMMUNOGENIC HPV L2-CONTAINING VLPS AND RELATED COMPOSITIONS AND METHODS
    236.
    发明公开
    IMMUNOGENIC HPV L2-CONTAINING VLPS AND RELATED COMPOSITIONS AND METHODS 有权
    免疫原性HPV病毒样颗粒L2基于和相关组合物和方法

    公开(公告)号:EP2802349A1

    公开(公告)日:2014-11-19

    申请号:EP13736349.5

    申请日:2013-01-10

    Applicant: STC.UNM

    Abstract: In one aspect, the invention provides immunogenic HPV L2-containing viral-like particles (VLPs). Related compositions (e.g. vaccines), nucleic acid constructs, and therapeutic methods are also provided. In certain aspects, the VLPs are comprised of a coat polypeptide of the bacteriophages PP7 or MS2, wherein the coat protein is modified by insertion of peptide antigens derived from HPV L2, and wherein the HPV L2 peptide is displayed on the VLP and encapsidates PP7 or MS2 mRNA. Specifically, VLPs of the invention display L2 peptides at the N- terminus of the bacteriophage coat protein. Surprisingly, these L2-displaying VLPs induce more broadly neutralizing antibody responses than when the same peptide is displayed in the AB-loop such that the immunogenic response is enhanced by a factor of at least 10. Immunogenic VLPs and related compositions of the invention induce high titer antibody responses against HPV L2 and protect against HPV challenge
    in vivo.

Patent Agency Ranking